Stem cell therapy for cardiovascular diseases: Are we still at the beginning of a long road?

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 10, Issue 3, 2010, Pages 158-160

  Gonçalves, Lino M ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ADIPOSE TISSUE CELL; BONE MARROW CELL; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CELL CULTURE; CLINICAL PRACTICE; EDITORIAL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MESENCHYME CELL; MYOBLAST; STEM CELL TRANSPLANTATION;

CARDIOVASCULAR DISEASES; HUMANS; STEM CELL TRANSPLANTATION;

EID: 78549289197     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Poss, K.D.; Wilson, L.G.; Keating, M.T. Heart regeneration in zebrafish. Science, 2002, 298, 2188-90.
2. Bettencourt-Dias, M.; Mittnacht, S.; Brockes, J.P. Heterogenous proliferative potential in regenerative adult newt cardiomyocytes. J. Cell Sci., 2003, 116, 4001-9.
3. Pasumarthi, K.B.; Nakajima, H.; Nakajima, H.O.; Soonpaa, M.H.; Field, L.J. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis.and infarct regression in transgenic mice. Circ. Res., 2005, 96, 110-8.
4. Beauchamp, J.R.; Morgan, J.E.; Pagel, C.N., Partridge, T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol., 1999, 144, 626-33.
5. Forest, V.F.; Tirouvanziam, A.M.; Perigaud, C.; Fernandes, S.; Fusellier, M.S.; Desfontis, J.C.; Toquet, C.S.; Heymann, M.F.; Crochet, D.P.; Lemarchand, P.F. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Res. Ther., 2010, 15, 1(1), 4.
6. Aicher, A.; Brenner, W.; Zuhayra, M.; Badorff, C.; Massoudi, S.; Assmus, B.; Eckey, T.; Henze, E.; Zeiher, A.M.; Dimmeler, S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation, 2003, 107, 2134-9.
7. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S.M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D.M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature, 2001, 410, 701-5.
8. Zhang, Y.M.; Hartzell, C.; Narlow, M.; Dudley, Jr.S.C., Stem cell derived cardiomyocytes demonstrate arrhythmic potential. Circulation, 2002, 106, 1294-9.
9. Koh, G.Y.; Klug, M.G.; Soonpaa, M.H.; Field, L.J. Differentiation and long-term survival of c2c12 myoblast grafts in heart. J. Clin. Invest., 1993, 92, 1548-1554.
10. Taylor, D.A.; Atkins, B.Z.; Hungspreugs, P.; Jones, T.R.; Reedy, M.C.; Hutcheson, K.A.; Glower, D.D.; Kraus, W.E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med., 1998, 4, 929-33.
11. Menasché, P.; Hagège, A.A.; Vilquin, J.T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J.P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol., 2003, 41, 1078-83.
12. Reinecke, H.; Poppa, V.; Murry, C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol., 2002, 34, 241-9.
13. Leobon, B.; Garcin, I.; Menasche, P.; Vilquin, J.T.; Audinat, E.; Chapak, S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. USA, 2003, 100, 7808-11.
14. Perin, E.C.; Dohmann, H.F.; Borojevic, R.; Silva, S.A.; Sousa, A.L.; Mesquita, C.T.; Rossi, M.I.; Carvalho, A.C.; Dutra, H.S.; Dohmann, H.J.; Silva, G.V.; Belém, L.; Vivacqua, R.; Rangel, F.O.; Esporcatte, R.; Geng, Y.J.; Vaughn, W.K.; Assad, J.A.; Mesquita, E.T.; Willerson, J.T. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 2003, 107, 2294-302.
15. Yoon, Y.S.; Park, J.S.; Tkebuchava, T.; Luedeman, C.; Losordo, D.W. Unexpected severe calcification after transplantation of bone-marrow cells in acute myocardial infarction. Circulation, 2004, 109, 3154-7.
16. Rafii, S.; Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med., 2003, 9, 702-12.
17. Frangogiannis, N.G.; Smith, C.W.; Entman, M.I. The inflammatory response in myocardial infarction. Cardiovasc. Res., 2002, 53, 31-47.
18. Lee, M.S.; Makkar, R.R. Stem-cell transplantation in myocardial infarction: a status report. Ann. Intern. Med., 2004, 140, 729-37.
19. Murry, C.E.; Soonpaa, M.H.; Reinecke, H.; Nakajima, H.; Nakajima, H.O.; Rubart, M.; Pasumarthi, K.B.; Virag, J.I.; Bartelmez, S.H.; Poppa, V.; Bradford, G.; Dowell, J.D.; Williams, D.A.; Field, L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 2004, 428, 664-8.
20. Nygren, J.M.; Jovinge, S.; Breitbach, M.; Säwén, P.; Röll, W.; Hescheler, J.; Taneera, J.; Fleischmann, B.K.; Jacobsen, S.E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature, 2004, 10, 494-501.
21. Nguyen, B.K.; Maltais, S.; Perrault, L.P.; Tanguay, J.F.; Tardif, J.C.; Stevens, L.M.; Borie, M.; Harel, F.; Mansour, S.; Noiseux, N. J Cardiovasc Transl Res. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. 2010 Feb 26 [Epub ahead of print].
22. Strauer, B.E.; Yousef, M.; Schannwell, C.M. The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur. J. Heart Fail., 2010,12(7), 721-9.
23. Samper, E.; Flores, J.M.; Blasco, M.A. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Rep., 2001, 2, 800-7.
24. Mangi, A.A.; Noiseux, N.; Kong, D.; He, H.; Rezvani, M.; Ingwall, J.S.; Dzau, V.J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med., 2003, 93, 1195-201.
25. McCormick, J.B.; Huso, H.A. Stem cells and ethics: current issues. J. Cardiovasc. Transl. Res., 2010, 3(2), 122-7.